Global Blood Tests for Alzheimer's Diagnosis Market Growth (Status and Outlook) 2026-2032
The global Blood Tests for Alzheimer's Diagnosis market size is predicted to grow from US$ 70.58 million in 2025 to US$ 128 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032.
Blood Tests for Alzheimer's Diagnosis refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Blood Tests for Alzheimer's Diagnosis mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer?s disease biomarker research.
The Blood Tests for Alzheimer's Diagnosis market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
LPI (LP Information)' newest research report, the ?Blood Tests for Alzheimer's Diagnosis Industry Forecast? looks at past sales and reviews total world Blood Tests for Alzheimer's Diagnosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Tests for Alzheimer's Diagnosis sales for 2026 through 2032. With Blood Tests for Alzheimer's Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Tests for Alzheimer's Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Blood Tests for Alzheimer's Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood Tests for Alzheimer's Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood Tests for Alzheimer's Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Tests for Alzheimer's Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Tests for Alzheimer's Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Tests for Alzheimer's Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Blood Tests for Alzheimer's Diagnosis refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Blood Tests for Alzheimer's Diagnosis mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer?s disease biomarker research.
The Blood Tests for Alzheimer's Diagnosis market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
LPI (LP Information)' newest research report, the ?Blood Tests for Alzheimer's Diagnosis Industry Forecast? looks at past sales and reviews total world Blood Tests for Alzheimer's Diagnosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Tests for Alzheimer's Diagnosis sales for 2026 through 2032. With Blood Tests for Alzheimer's Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Tests for Alzheimer's Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Blood Tests for Alzheimer's Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood Tests for Alzheimer's Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood Tests for Alzheimer's Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Tests for Alzheimer's Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Tests for Alzheimer's Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Tests for Alzheimer's Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Single Biomarker Tests
- Multi-Biomarker Panel Tests
- Others
- Chemiluminescent Immunoassay
- Single-Molecule and Ultra-Sensitive Immunoassay
- Mass Spectrometry-Based Testing
- Others
- Clinical Use
- Non-Clinical Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Fujirebio
- Sysmex
- Shimadzu
- Diadem
- Quanterix
- ALZpath
- Beckman Coulter Diagnostics
- Siemens Healthineers
- Vazyme
- Hoyotek
- BGI Genomics
- Kemei Diagnostics
- Maya Lightyear
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Tests for Alzheimer's Diagnosis Market Size (2021-2032)
2.1.2 Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Blood Tests for Alzheimer's Diagnosis by Country/Region (2021, 2025 & 2032)
2.2 Blood Tests for Alzheimer's Diagnosis Segment by Type
2.2.1 Single Biomarker Tests
2.2.2 Multi-Biomarker Panel Tests
2.2.3 Others
2.2.4 Blood Tests for Alzheimer's Diagnosis Market Size by Type
2.2.4.1 Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
2.3 Blood Tests for Alzheimer's Diagnosis Segment Commercialization Status
2.3.1 Chemiluminescent Immunoassay
2.3.2 Single-Molecule and Ultra-Sensitive Immunoassay
2.3.3 Mass Spectrometry-Based Testing
2.3.4 Others
2.3.5 Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status
2.3.5.1 Blood Tests for Alzheimer's Diagnosis Market Size CAGR Commercialization Status (2021 VS 2025 VS 2032)
2.3.5.2 Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2021-2026)
2.4 Blood Tests for Alzheimer's Diagnosis Segment by Application
2.4.1 Clinical Use
2.4.2 Non-Clinical Use
2.4.3 Blood Tests for Alzheimer's Diagnosis Market Size by Application
2.4.3.1 Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.3.2 Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
3 BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Player
3.1.1 Global Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026)
3.1.2 Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Player (2021-2026)
3.2 Global Blood Tests for Alzheimer's Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS BY REGION
4.1 Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026)
4.2 Global Blood Tests for Alzheimer's Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
4.4 APAC Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
4.5 Europe Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
4.6 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026)
5.2 Americas Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
5.3 Americas Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026)
6.2 APAC Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
6.3 APAC Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis by Region (2021-2026)
8.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
8.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS MARKET FORECAST
10.1 Global Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.1.1 Global Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.1.2 Americas Blood Tests for Alzheimer's Diagnosis Forecast
10.1.3 APAC Blood Tests for Alzheimer's Diagnosis Forecast
10.1.4 Europe Blood Tests for Alzheimer's Diagnosis Forecast
10.1.5 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Forecast
10.2 Americas Blood Tests for Alzheimer's Diagnosis Forecast by Country (2027-2032)
10.2.1 United States Market Blood Tests for Alzheimer's Diagnosis Forecast
10.2.2 Canada Market Blood Tests for Alzheimer's Diagnosis Forecast
10.2.3 Mexico Market Blood Tests for Alzheimer's Diagnosis Forecast
10.2.4 Brazil Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3 APAC Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.3.1 China Blood Tests for Alzheimer's Diagnosis Market Forecast
10.3.2 Japan Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.3 Korea Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.4 Southeast Asia Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.5 India Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.6 Australia Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4 Europe Blood Tests for Alzheimer's Diagnosis Forecast by Country (2027-2032)
10.4.1 Germany Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.2 France Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.3 UK Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.4 Italy Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.5 Russia Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.5.1 Egypt Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5.2 South Africa Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5.3 Israel Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5.4 Turkey Market Blood Tests for Alzheimer's Diagnosis Forecast
10.6 Global Blood Tests for Alzheimer's Diagnosis Forecast by Type (2027-2032)
10.7 Global Blood Tests for Alzheimer's Diagnosis Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Blood Tests for Alzheimer's Diagnosis Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Blood Tests for Alzheimer's Diagnosis Product Offered
11.1.3 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Fujirebio
11.2.1 Fujirebio Company Information
11.2.2 Fujirebio Blood Tests for Alzheimer's Diagnosis Product Offered
11.2.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fujirebio Main Business Overview
11.2.5 Fujirebio Latest Developments
11.3 Sysmex
11.3.1 Sysmex Company Information
11.3.2 Sysmex Blood Tests for Alzheimer's Diagnosis Product Offered
11.3.3 Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sysmex Main Business Overview
11.3.5 Sysmex Latest Developments
11.4 Shimadzu
11.4.1 Shimadzu Company Information
11.4.2 Shimadzu Blood Tests for Alzheimer's Diagnosis Product Offered
11.4.3 Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Shimadzu Main Business Overview
11.4.5 Shimadzu Latest Developments
11.5 Diadem
11.5.1 Diadem Company Information
11.5.2 Diadem Blood Tests for Alzheimer's Diagnosis Product Offered
11.5.3 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Diadem Main Business Overview
11.5.5 Diadem Latest Developments
11.6 Quanterix
11.6.1 Quanterix Company Information
11.6.2 Quanterix Blood Tests for Alzheimer's Diagnosis Product Offered
11.6.3 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Quanterix Main Business Overview
11.6.5 Quanterix Latest Developments
11.7 ALZpath
11.7.1 ALZpath Company Information
11.7.2 ALZpath Blood Tests for Alzheimer's Diagnosis Product Offered
11.7.3 ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ALZpath Main Business Overview
11.7.5 ALZpath Latest Developments
11.8 Beckman Coulter Diagnostics
11.8.1 Beckman Coulter Diagnostics Company Information
11.8.2 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
11.8.3 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Beckman Coulter Diagnostics Main Business Overview
11.8.5 Beckman Coulter Diagnostics Latest Developments
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Information
11.9.2 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product Offered
11.9.3 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Siemens Healthineers Main Business Overview
11.9.5 Siemens Healthineers Latest Developments
11.10 Vazyme
11.10.1 Vazyme Company Information
11.10.2 Vazyme Blood Tests for Alzheimer's Diagnosis Product Offered
11.10.3 Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Vazyme Main Business Overview
11.10.5 Vazyme Latest Developments
11.11 Hoyotek
11.11.1 Hoyotek Company Information
11.11.2 Hoyotek Blood Tests for Alzheimer's Diagnosis Product Offered
11.11.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Hoyotek Main Business Overview
11.11.5 Hoyotek Latest Developments
11.12 BGI Genomics
11.12.1 BGI Genomics Company Information
11.12.2 BGI Genomics Blood Tests for Alzheimer's Diagnosis Product Offered
11.12.3 BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BGI Genomics Main Business Overview
11.12.5 BGI Genomics Latest Developments
11.13 Kemei Diagnostics
11.13.1 Kemei Diagnostics Company Information
11.13.2 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
11.13.3 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kemei Diagnostics Main Business Overview
11.13.5 Kemei Diagnostics Latest Developments
11.14 Maya Lightyear
11.14.1 Maya Lightyear Company Information
11.14.2 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product Offered
11.14.3 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Maya Lightyear Main Business Overview
11.14.5 Maya Lightyear Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Tests for Alzheimer's Diagnosis Market Size (2021-2032)
2.1.2 Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Blood Tests for Alzheimer's Diagnosis by Country/Region (2021, 2025 & 2032)
2.2 Blood Tests for Alzheimer's Diagnosis Segment by Type
2.2.1 Single Biomarker Tests
2.2.2 Multi-Biomarker Panel Tests
2.2.3 Others
2.2.4 Blood Tests for Alzheimer's Diagnosis Market Size by Type
2.2.4.1 Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
2.3 Blood Tests for Alzheimer's Diagnosis Segment Commercialization Status
2.3.1 Chemiluminescent Immunoassay
2.3.2 Single-Molecule and Ultra-Sensitive Immunoassay
2.3.3 Mass Spectrometry-Based Testing
2.3.4 Others
2.3.5 Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status
2.3.5.1 Blood Tests for Alzheimer's Diagnosis Market Size CAGR Commercialization Status (2021 VS 2025 VS 2032)
2.3.5.2 Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2021-2026)
2.4 Blood Tests for Alzheimer's Diagnosis Segment by Application
2.4.1 Clinical Use
2.4.2 Non-Clinical Use
2.4.3 Blood Tests for Alzheimer's Diagnosis Market Size by Application
2.4.3.1 Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.3.2 Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
3 BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Player
3.1.1 Global Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026)
3.1.2 Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Player (2021-2026)
3.2 Global Blood Tests for Alzheimer's Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS BY REGION
4.1 Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026)
4.2 Global Blood Tests for Alzheimer's Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
4.4 APAC Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
4.5 Europe Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
4.6 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026)
5.2 Americas Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
5.3 Americas Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026)
6.2 APAC Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
6.3 APAC Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis by Region (2021-2026)
8.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
8.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS MARKET FORECAST
10.1 Global Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.1.1 Global Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.1.2 Americas Blood Tests for Alzheimer's Diagnosis Forecast
10.1.3 APAC Blood Tests for Alzheimer's Diagnosis Forecast
10.1.4 Europe Blood Tests for Alzheimer's Diagnosis Forecast
10.1.5 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Forecast
10.2 Americas Blood Tests for Alzheimer's Diagnosis Forecast by Country (2027-2032)
10.2.1 United States Market Blood Tests for Alzheimer's Diagnosis Forecast
10.2.2 Canada Market Blood Tests for Alzheimer's Diagnosis Forecast
10.2.3 Mexico Market Blood Tests for Alzheimer's Diagnosis Forecast
10.2.4 Brazil Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3 APAC Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.3.1 China Blood Tests for Alzheimer's Diagnosis Market Forecast
10.3.2 Japan Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.3 Korea Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.4 Southeast Asia Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.5 India Market Blood Tests for Alzheimer's Diagnosis Forecast
10.3.6 Australia Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4 Europe Blood Tests for Alzheimer's Diagnosis Forecast by Country (2027-2032)
10.4.1 Germany Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.2 France Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.3 UK Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.4 Italy Market Blood Tests for Alzheimer's Diagnosis Forecast
10.4.5 Russia Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Forecast by Region (2027-2032)
10.5.1 Egypt Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5.2 South Africa Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5.3 Israel Market Blood Tests for Alzheimer's Diagnosis Forecast
10.5.4 Turkey Market Blood Tests for Alzheimer's Diagnosis Forecast
10.6 Global Blood Tests for Alzheimer's Diagnosis Forecast by Type (2027-2032)
10.7 Global Blood Tests for Alzheimer's Diagnosis Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Blood Tests for Alzheimer's Diagnosis Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Blood Tests for Alzheimer's Diagnosis Product Offered
11.1.3 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Fujirebio
11.2.1 Fujirebio Company Information
11.2.2 Fujirebio Blood Tests for Alzheimer's Diagnosis Product Offered
11.2.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fujirebio Main Business Overview
11.2.5 Fujirebio Latest Developments
11.3 Sysmex
11.3.1 Sysmex Company Information
11.3.2 Sysmex Blood Tests for Alzheimer's Diagnosis Product Offered
11.3.3 Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sysmex Main Business Overview
11.3.5 Sysmex Latest Developments
11.4 Shimadzu
11.4.1 Shimadzu Company Information
11.4.2 Shimadzu Blood Tests for Alzheimer's Diagnosis Product Offered
11.4.3 Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Shimadzu Main Business Overview
11.4.5 Shimadzu Latest Developments
11.5 Diadem
11.5.1 Diadem Company Information
11.5.2 Diadem Blood Tests for Alzheimer's Diagnosis Product Offered
11.5.3 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Diadem Main Business Overview
11.5.5 Diadem Latest Developments
11.6 Quanterix
11.6.1 Quanterix Company Information
11.6.2 Quanterix Blood Tests for Alzheimer's Diagnosis Product Offered
11.6.3 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Quanterix Main Business Overview
11.6.5 Quanterix Latest Developments
11.7 ALZpath
11.7.1 ALZpath Company Information
11.7.2 ALZpath Blood Tests for Alzheimer's Diagnosis Product Offered
11.7.3 ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ALZpath Main Business Overview
11.7.5 ALZpath Latest Developments
11.8 Beckman Coulter Diagnostics
11.8.1 Beckman Coulter Diagnostics Company Information
11.8.2 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
11.8.3 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Beckman Coulter Diagnostics Main Business Overview
11.8.5 Beckman Coulter Diagnostics Latest Developments
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Information
11.9.2 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product Offered
11.9.3 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Siemens Healthineers Main Business Overview
11.9.5 Siemens Healthineers Latest Developments
11.10 Vazyme
11.10.1 Vazyme Company Information
11.10.2 Vazyme Blood Tests for Alzheimer's Diagnosis Product Offered
11.10.3 Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Vazyme Main Business Overview
11.10.5 Vazyme Latest Developments
11.11 Hoyotek
11.11.1 Hoyotek Company Information
11.11.2 Hoyotek Blood Tests for Alzheimer's Diagnosis Product Offered
11.11.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Hoyotek Main Business Overview
11.11.5 Hoyotek Latest Developments
11.12 BGI Genomics
11.12.1 BGI Genomics Company Information
11.12.2 BGI Genomics Blood Tests for Alzheimer's Diagnosis Product Offered
11.12.3 BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BGI Genomics Main Business Overview
11.12.5 BGI Genomics Latest Developments
11.13 Kemei Diagnostics
11.13.1 Kemei Diagnostics Company Information
11.13.2 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
11.13.3 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kemei Diagnostics Main Business Overview
11.13.5 Kemei Diagnostics Latest Developments
11.14 Maya Lightyear
11.14.1 Maya Lightyear Company Information
11.14.2 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product Offered
11.14.3 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Maya Lightyear Main Business Overview
11.14.5 Maya Lightyear Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Blood Tests for Alzheimer's Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Biomarker Tests
Table 4. Major Players of Multi-Biomarker Panel Tests
Table 5. Major Players of Others
Table 6. Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Chemiluminescent Immunoassay
Table 10. Major Players of Single-Molecule and Ultra-Sensitive Immunoassay
Table 11. Major Players of Mass Spectrometry-Based Testing
Table 12. Major Players of Others
Table 13. Blood Tests for Alzheimer's Diagnosis Market Size CAGR Commercialization Status (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2021-2026) & ($ millions)
Table 15. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2021-2026)
Table 16. Major Players of Commercialized Products
Table 17. Major Players of Products under Development or Registration
Table 18. Major Players of Research Use Only Products
Table 19. Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 21. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Table 22. Global Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026) & ($ millions)
Table 23. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Player (2021-2026)
Table 24. Blood Tests for Alzheimer's Diagnosis Key Players Head office and Products Offered
Table 25. Blood Tests for Alzheimer's Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 29. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Table 30. Global Blood Tests for Alzheimer's Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Country (2021-2026)
Table 34. Americas Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Table 36. Americas Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Table 38. APAC Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Table 40. APAC Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Country (2021-2026)
Table 44. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of Blood Tests for Alzheimer's Diagnosis
Table 50. Key Market Challenges & Risks of Blood Tests for Alzheimer's Diagnosis
Table 51. Key Industry Trends of Blood Tests for Alzheimer's Diagnosis
Table 52. Global Blood Tests for Alzheimer's Diagnosis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global Blood Tests for Alzheimer's Diagnosis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global Blood Tests for Alzheimer's Diagnosis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Roche Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 57. Roche Blood Tests for Alzheimer's Diagnosis Product Offered
Table 58. Roche Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Fujirebio Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 62. Fujirebio Blood Tests for Alzheimer's Diagnosis Product Offered
Table 63. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Fujirebio Main Business
Table 65. Fujirebio Latest Developments
Table 66. Sysmex Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 67. Sysmex Blood Tests for Alzheimer's Diagnosis Product Offered
Table 68. Sysmex Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sysmex Main Business
Table 70. Sysmex Latest Developments
Table 71. Shimadzu Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 72. Shimadzu Blood Tests for Alzheimer's Diagnosis Product Offered
Table 73. Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Shimadzu Main Business
Table 75. Shimadzu Latest Developments
Table 76. Diadem Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 77. Diadem Blood Tests for Alzheimer's Diagnosis Product Offered
Table 78. Diadem Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Diadem Main Business
Table 80. Diadem Latest Developments
Table 81. Quanterix Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 82. Quanterix Blood Tests for Alzheimer's Diagnosis Product Offered
Table 83. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Quanterix Main Business
Table 85. Quanterix Latest Developments
Table 86. ALZpath Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 87. ALZpath Blood Tests for Alzheimer's Diagnosis Product Offered
Table 88. ALZpath Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. ALZpath Main Business
Table 90. ALZpath Latest Developments
Table 91. Beckman Coulter Diagnostics Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 92. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
Table 93. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Beckman Coulter Diagnostics Main Business
Table 95. Beckman Coulter Diagnostics Latest Developments
Table 96. Siemens Healthineers Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 97. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product Offered
Table 98. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Siemens Healthineers Main Business
Table 100. Siemens Healthineers Latest Developments
Table 101. Vazyme Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 102. Vazyme Blood Tests for Alzheimer's Diagnosis Product Offered
Table 103. Vazyme Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Vazyme Main Business
Table 105. Vazyme Latest Developments
Table 106. Hoyotek Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 107. Hoyotek Blood Tests for Alzheimer's Diagnosis Product Offered
Table 108. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Hoyotek Main Business
Table 110. Hoyotek Latest Developments
Table 111. BGI Genomics Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 112. BGI Genomics Blood Tests for Alzheimer's Diagnosis Product Offered
Table 113. BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. BGI Genomics Main Business
Table 115. BGI Genomics Latest Developments
Table 116. Kemei Diagnostics Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 117. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
Table 118. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Kemei Diagnostics Main Business
Table 120. Kemei Diagnostics Latest Developments
Table 121. Maya Lightyear Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 122. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product Offered
Table 123. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Maya Lightyear Main Business
Table 125. Maya Lightyear Latest Developments
Table 1. Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Blood Tests for Alzheimer's Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Biomarker Tests
Table 4. Major Players of Multi-Biomarker Panel Tests
Table 5. Major Players of Others
Table 6. Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Chemiluminescent Immunoassay
Table 10. Major Players of Single-Molecule and Ultra-Sensitive Immunoassay
Table 11. Major Players of Mass Spectrometry-Based Testing
Table 12. Major Players of Others
Table 13. Blood Tests for Alzheimer's Diagnosis Market Size CAGR Commercialization Status (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2021-2026) & ($ millions)
Table 15. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2021-2026)
Table 16. Major Players of Commercialized Products
Table 17. Major Players of Products under Development or Registration
Table 18. Major Players of Research Use Only Products
Table 19. Blood Tests for Alzheimer's Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 21. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Table 22. Global Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026) & ($ millions)
Table 23. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Player (2021-2026)
Table 24. Blood Tests for Alzheimer's Diagnosis Key Players Head office and Products Offered
Table 25. Blood Tests for Alzheimer's Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 29. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Table 30. Global Blood Tests for Alzheimer's Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Country (2021-2026)
Table 34. Americas Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Table 36. Americas Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Table 38. APAC Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Table 40. APAC Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Country (2021-2026)
Table 44. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of Blood Tests for Alzheimer's Diagnosis
Table 50. Key Market Challenges & Risks of Blood Tests for Alzheimer's Diagnosis
Table 51. Key Industry Trends of Blood Tests for Alzheimer's Diagnosis
Table 52. Global Blood Tests for Alzheimer's Diagnosis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global Blood Tests for Alzheimer's Diagnosis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global Blood Tests for Alzheimer's Diagnosis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Roche Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 57. Roche Blood Tests for Alzheimer's Diagnosis Product Offered
Table 58. Roche Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Fujirebio Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 62. Fujirebio Blood Tests for Alzheimer's Diagnosis Product Offered
Table 63. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Fujirebio Main Business
Table 65. Fujirebio Latest Developments
Table 66. Sysmex Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 67. Sysmex Blood Tests for Alzheimer's Diagnosis Product Offered
Table 68. Sysmex Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sysmex Main Business
Table 70. Sysmex Latest Developments
Table 71. Shimadzu Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 72. Shimadzu Blood Tests for Alzheimer's Diagnosis Product Offered
Table 73. Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Shimadzu Main Business
Table 75. Shimadzu Latest Developments
Table 76. Diadem Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 77. Diadem Blood Tests for Alzheimer's Diagnosis Product Offered
Table 78. Diadem Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Diadem Main Business
Table 80. Diadem Latest Developments
Table 81. Quanterix Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 82. Quanterix Blood Tests for Alzheimer's Diagnosis Product Offered
Table 83. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Quanterix Main Business
Table 85. Quanterix Latest Developments
Table 86. ALZpath Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 87. ALZpath Blood Tests for Alzheimer's Diagnosis Product Offered
Table 88. ALZpath Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. ALZpath Main Business
Table 90. ALZpath Latest Developments
Table 91. Beckman Coulter Diagnostics Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 92. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
Table 93. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Beckman Coulter Diagnostics Main Business
Table 95. Beckman Coulter Diagnostics Latest Developments
Table 96. Siemens Healthineers Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 97. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product Offered
Table 98. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Siemens Healthineers Main Business
Table 100. Siemens Healthineers Latest Developments
Table 101. Vazyme Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 102. Vazyme Blood Tests for Alzheimer's Diagnosis Product Offered
Table 103. Vazyme Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Vazyme Main Business
Table 105. Vazyme Latest Developments
Table 106. Hoyotek Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 107. Hoyotek Blood Tests for Alzheimer's Diagnosis Product Offered
Table 108. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Hoyotek Main Business
Table 110. Hoyotek Latest Developments
Table 111. BGI Genomics Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 112. BGI Genomics Blood Tests for Alzheimer's Diagnosis Product Offered
Table 113. BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. BGI Genomics Main Business
Table 115. BGI Genomics Latest Developments
Table 116. Kemei Diagnostics Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 117. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product Offered
Table 118. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Kemei Diagnostics Main Business
Table 120. Kemei Diagnostics Latest Developments
Table 121. Maya Lightyear Details, Company Type, Blood Tests for Alzheimer's Diagnosis Area Served and Its Competitors
Table 122. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product Offered
Table 123. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Maya Lightyear Main Business
Table 125. Maya Lightyear Latest Developments
LIST OF FIGURES
Figure 1. Blood Tests for Alzheimer's Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Blood Tests for Alzheimer's Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Blood Tests for Alzheimer's Diagnosis Sales Market Share by Country/Region (2025)
Figure 8. Blood Tests for Alzheimer's Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type in 2025
Figure 10. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status in 2025
Figure 11. Blood Tests for Alzheimer's Diagnosis in Clinical Use
Figure 12. Global Blood Tests for Alzheimer's Diagnosis Market: Clinical Use (2021-2026) & ($ millions)
Figure 13. Blood Tests for Alzheimer's Diagnosis in Non-Clinical Use
Figure 14. Global Blood Tests for Alzheimer's Diagnosis Market: Non-Clinical Use (2021-2026) & ($ millions)
Figure 15. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application in 2025
Figure 16. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Player in 2025
Figure 17. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Figure 18. Americas Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 19. APAC Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 20. Europe Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 21. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 22. Americas Blood Tests for Alzheimer's Diagnosis Value Market Share by Country in 2025
Figure 23. United States Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 24. Canada Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 25. Mexico Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 26. Brazil Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 27. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region in 2025
Figure 28. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Figure 29. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Figure 30. China Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 31. Japan Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 32. South Korea Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 33. Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 34. India Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 35. Australia Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 36. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Country in 2025
Figure 37. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Figure 38. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Figure 39. Germany Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 40. France Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 41. UK Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 42. Italy Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 43. Russia Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 44. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Figure 45. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Figure 46. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Figure 47. Egypt Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 48. South Africa Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 49. Israel Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 50. Turkey Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 51. GCC Countries Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 52. Americas Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 53. APAC Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 54. Europe Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 55. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 56. United States Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 57. Canada Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 58. Mexico Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 59. Brazil Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 60. China Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 61. Japan Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 62. Korea Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 63. Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 64. India Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 65. Australia Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 66. Germany Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 67. France Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 68. UK Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 69. Italy Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 70. Russia Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 71. Egypt Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 72. South Africa Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 73. Israel Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 74. Turkey Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 75. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Forecast by Type (2027-2032)
Figure 76. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Forecast by Application (2027-2032)
Figure 77. GCC Countries Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 1. Blood Tests for Alzheimer's Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Blood Tests for Alzheimer's Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Blood Tests for Alzheimer's Diagnosis Sales Market Share by Country/Region (2025)
Figure 8. Blood Tests for Alzheimer's Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type in 2025
Figure 10. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status in 2025
Figure 11. Blood Tests for Alzheimer's Diagnosis in Clinical Use
Figure 12. Global Blood Tests for Alzheimer's Diagnosis Market: Clinical Use (2021-2026) & ($ millions)
Figure 13. Blood Tests for Alzheimer's Diagnosis in Non-Clinical Use
Figure 14. Global Blood Tests for Alzheimer's Diagnosis Market: Non-Clinical Use (2021-2026) & ($ millions)
Figure 15. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application in 2025
Figure 16. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Player in 2025
Figure 17. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Figure 18. Americas Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 19. APAC Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 20. Europe Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 21. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size 2021-2026 ($ millions)
Figure 22. Americas Blood Tests for Alzheimer's Diagnosis Value Market Share by Country in 2025
Figure 23. United States Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 24. Canada Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 25. Mexico Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 26. Brazil Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 27. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region in 2025
Figure 28. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Figure 29. APAC Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Figure 30. China Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 31. Japan Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 32. South Korea Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 33. Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 34. India Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 35. Australia Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 36. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Country in 2025
Figure 37. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Figure 38. Europe Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Figure 39. Germany Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 40. France Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 41. UK Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 42. Italy Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 43. Russia Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 44. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Region (2021-2026)
Figure 45. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2026)
Figure 46. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2026)
Figure 47. Egypt Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 48. South Africa Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 49. Israel Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 50. Turkey Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 51. GCC Countries Blood Tests for Alzheimer's Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 52. Americas Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 53. APAC Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 54. Europe Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 55. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 56. United States Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 57. Canada Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 58. Mexico Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 59. Brazil Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 60. China Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 61. Japan Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 62. Korea Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 63. Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 64. India Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 65. Australia Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 66. Germany Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 67. France Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 68. UK Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 69. Italy Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 70. Russia Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 71. Egypt Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 72. South Africa Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 73. Israel Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 74. Turkey Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
Figure 75. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Forecast by Type (2027-2032)
Figure 76. Global Blood Tests for Alzheimer's Diagnosis Market Size Market Share Forecast by Application (2027-2032)
Figure 77. GCC Countries Blood Tests for Alzheimer's Diagnosis Market Size 2027-2032 ($ millions)
